Your cart
Your cart is empty.HEALTH NEWS
Study Title:
Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk b
Study Abstract
Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection.
Study Information
Molecules. 2022 Jan 23;27(3):738. doi: 10.3390/molecules27030738. PMID: 35164003; PMCID: PMC8839434.